Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Female Participants”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Early research (Phase 1)Study completedNCT07404137
What this trial is testing

Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Who this might be right for
Healthy Participants
AstraZeneca 26
Early research (Phase 1)Study completedNCT05495581
What this trial is testing

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 28
Early research (Phase 1)Study completedNCT05877222
What this trial is testing

Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants

Who this might be right for
Healthy
Idorsia Pharmaceuticals Ltd. 38
Early research (Phase 1)Study completedNCT04641260
What this trial is testing

Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Who this might be right for
Healthy Subjects
Astellas Pharma Global Development, Inc. 16
Early research (Phase 1)Study completedNCT05579574
What this trial is testing

Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 42
Early research (Phase 1)Study completedNCT05064332
What this trial is testing

Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

Who this might be right for
Healthy
Pfizer 10
Early research (Phase 1)Study completedNCT03381664
What this trial is testing

Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants

Who this might be right for
Healthy Adult Male and Female Volunteers
Avanir Pharmaceuticals 17
Early research (Phase 1)Study completedNCT06908707
What this trial is testing

Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women

Who this might be right for
PostmenopausalHealthy Adult Female Participants
Laekna Limited 32
Early research (Phase 1)Study completedNCT04991571
What this trial is testing

Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants

Who this might be right for
Chronic Kidney Disease
AstraZeneca 27
Early research (Phase 1)Study completedNCT06497517
What this trial is testing

Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants

Who this might be right for
Cough
Bellus Health Inc. - a GSK company 14
Early research (Phase 1)Study completedNCT06128954
What this trial is testing

Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).

Who this might be right for
Wilson's Disease
Orphalan 26
Early research (Phase 1)UnknownNCT01913834
What this trial is testing

Nasally and sc Administered Teriparatide in Healthy Volunteers

Who this might be right for
Osteoporosis
Nottingham University Hospitals NHS Trust 7
Early research (Phase 1)Study completedNCT05444556
What this trial is testing

Imlunestrant (LY3484356) in Female Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 113
Early research (Phase 1)Looking for participantsNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Early research (Phase 1)Ended earlyNCT04037865
What this trial is testing

A Renal Impairment Study for PF-06651600

Who this might be right for
Renal Impairment
Pfizer 8
Early research (Phase 1)Study completedNCT04899193
What this trial is testing

Pergoveris FD and Liquid China BE Study

Who this might be right for
Healthy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 72
Early research (Phase 1)Study completedNCT06547164
What this trial is testing

Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants

Who this might be right for
Healthy Participants
AstraZeneca 40
Early research (Phase 1)Study completedNCT04949438
What this trial is testing

Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy Volunteers

Who this might be right for
Renal Impairment
AstraZeneca 20
Early research (Phase 1)Looking for participantsNCT07235059
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 112
Load More Results